The cationic peptide magainin II is antimicrobial for Burkholderia cepacia-complex strains

Journal of Medical Microbiology

Volumn 58, Issue 7, 2009, Pages 923-929

  Thwaite, Joanne E ^a   Humphrey, Suzanne ^a   Fox, Marc A ^a   Savage, Victoria L ^a   Laws, Thomas R ^a   Ulaeto, David O ^a   Titball, Richard W ^b   Atkins, Helen S ^a  

^a DEFENCE SCIENCE AND TECHNOLOGY LABORATORY   (United Kingdom)

^b UNIVERSITY OF EXETER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MAGAININ 2; PROTEINASE;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BURKHOLDERIA CEPACIA COMPLEX; BURKHOLDERIA CEPACIA INFECTION; CONTROLLED STUDY; DRUG ISOLATION; FROG; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG FIBROSIS; NONHUMAN; PRIORITY JOURNAL; XENOPUS LAEVIS;

AMINO ACID SEQUENCE; ANTI-INFECTIVE AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; APOPTOSIS; BURKHOLDERIA CEPACIA COMPLEX; CELL LINE; DRUG STABILITY; EPITHELIAL CELLS; HUMANS; L-LACTATE DEHYDROGENASE; PEPTIDE HYDROLASES; RESPIRATORY MUCOSA; TIME FACTORS; XENOPUS PROTEINS;

EID: 67650169482     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.008128-0     Document Type: Article

References (47)

1. Agerberth, B., Gunne, J., Odeberg, P., Kogner, H., Boman, H. G. & Gudmundsson, G. H. (1995). FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis. Proc Natl Acad Sci U S A 92, 195-199.
2. Albiol Matanic, V. C. & Castilla, V. (2004). Antiviral activity of antimicrobial cationic peptides against Junin virus and herpes simplex virus. Int J Antimicrob Agents 23, 382-389. (Pubitemid 38481551)
3. Bessalle, R., Kapitkovsky, A., Gorea, A., Shalit, I. & Fridkin, M. (1990). All-D-magainin: chirality, antimicrobial activity and proteolytic resistance. FEBS Lett 274, 151-155. (Pubitemid 20378143)
4. Bobek, L. A. & Situ, H. (2003). MUC7 20-mer: investigation of antimicrobial activity, secondary structure, and possible mechanism of antifungal action. Antimicrob Agents Chemother 47, 643-652. (Pubitemid 36158095)
5. Bonacorsi, S., Fitoussi, F., Lhopital, S. & Bingen, B. (1999). Comparative in vitro activities of meropenem, imipenem, temocillin, piperacillin, and ceftazidime in combination with tobramycin, rifampin, or ciprofloxacin against Burkholderia cepacia isolates from patients with cystic fibrosis. Antimicrob Agents Chemother 43, 213-217. (Pubitemid 29079148)
6. Bowdish, D. M., Davidson, D. J., Scott, M. G. & Hancock, R. E. W. (2005). Immunomodulatory activities of small host defense peptides. Antimicrob Agents Chemother 49, 1727-1732. (Pubitemid 40631581)
7. Brogden, K. A., de Lucca, A. J., Bland, J. & Elliott, S. (1996). Isolation of an ovine pulmonary surfactant-associated peptide bactericidal for Pasteurella haemolytica. Proc Natl Acad Sci U S A 93, 412-416. (Pubitemid 26038168)
8. Chopra, I. (1993). The magainins: antimicrobial peptides with potential for topical application. J Antimicrob Chemother 32, 351-353. (Pubitemid 23295281)
9. Coenye, T., Vandamme, P., Govan, J. R. W. & Lipuma, J. J. (2001). Taxonomy and identification of the Burkholderia cepacia complex. J Clin Microbiol 39, 3427-3436. (Pubitemid 32954480)
10. Cole, A. M., Kim, Y. H., Tahk, S., Hong, T., Weis, P., Waring, A. J. & Ganz, T. (2001). Calcitermin, a novel antimicrobial peptide isolated from human airway secretions. FEBS Lett 504, 5-10. (Pubitemid 32777801)
11. Denyer, S. P. & Maillard, J. Y. (2002). Cellular impermeability and uptake of biocides and antibiotics in Gram-negative bacteria. J Appl Microbiol 92, 35S-45S.
12. Frackenpohl, J., Arvidsson, P. I., Schreiber, J. V. & Seebach, D. (2001). The outstanding biological stability of b- and c-peptides towards proteolytic enzymes: an in vitro investigation with fifteen peptidases. ChemBioChem 2, 445-455. (Pubitemid 33723576)
13. Fuchs, P. C., Barry, A. L. & Brown, S. D. (1998). In vitro antimicrobial activity of MSI-78, a magainin analog. Antimicrob Agents Chemother 42, 1213-1216.
14. Ganz, T. (2001). Fatal attraction evaded: how pathogenic bacteria resist cationic polypeptides. J Exp Med 193, F31-F33. (Pubitemid 32436192)
15. Giacometti, A., Cirioni, O., Prete, M. S., Barchiesi, F., Fortuna, M., Drenaggi, D. & Scalise, G. (2000). In vitro activities of membraneactive peptides alone and in combination with clinically used antimicrobial agents against Stenotrophomonas maltophilia. Antimicrob Agents Chemother 44, 1716-1719.
16. Giacometti, A., Cirioni, O., Kamysz, W., Silvestri, C., Licci, A., Riva, A., Lukasiak, J. & Scalise, G. (2005a). In vitro activity of amphibian peptides alone and in combination with antimicrobial agents against multidrug-resistant pathogens isolated from surgical wound infection. Peptides 26, 2111-2116.
17. Giacometti, A., Cirioni, O., Kamysz, W., D'Amato, G., Silvestri, C., Del Prete, M. S., Licci, A., Riva, A., Lukasiak, J. & Scalise, G. (2005b). In vitro activity of the histatin derivative P-113 against multidrugresistant pathogens responsible for pneumonia in immunocompromised patients. Antimicrob Agents Chemother 49, 1249-1252.
18. Giovannini, M. G., Poulter, L., Gibson, B. W. & Williams, D. H. (1987). Biosynthesis and degradation of peptides derived from Xenopus laevis prohormones. Biochem J 243, 113-120. (Pubitemid 17048890)
19. Gottler, L. M. & Ramamoorthy, A. (2008). Structure, membrane orientation, mechanism, and function of pexiganan - a highly potent antimicrobial peptide designed from magainin. Biochim Biophys Acta, (Epub ahead of print) doi:10.1016/j.bbamem. 2008.10.009
20. Guina, T., Yi, E. C., Wang, H. L., Hackett, M. & Miller, S. I. (2000). A PhoP-regulated outer membrane protease of Salmonella enterica serovar Typhimurim promotes resistance to a-helical antimicrobial peptides. J Bacteriol 182, 4077-4086. (Pubitemid 30436571)
21. Hancock, R. E. W. & Lehrer, R. (1998). Cationic peptides: a new source of antibiotics. Trends Biotechnol 16, 82-88. (Pubitemid 28055477)
22. Hancock, R. E. W. & Scott, M. G. (2000). The role of antimicrobial peptides in animal defenses. Proc Natl Acad Sci U S A 97, 8856-8861. (Pubitemid 30626637)
23. Holak, T. A., Engstroem, A., Kraulis, P. J., Lindeberg, G., Bennich, H., Jones, T. A., Gronenborn, A. M. & Clore, G. M. (1988). The solution conformation of the antibacterial peptide cecropin A: a nuclear magnetic resonance and dynamical simulated annealing study. Biochemistry 27, 7620-7629. (Pubitemid 18247513)
24. Isles, A., Maclusky, I., Corey, M., Gold, R., Prober, C., Fleming, P. & Levison, H. (1984). Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J Pediatr 104, 206-210. (Pubitemid 14188925)
25. Jones, A. M. & Webb, A. K. (2003). Recent advances in cross infection in cystic fibrosis: Burkholderia cepacia complex, Pseudomonas aeruginosa, MRSA and Pandorea spp. J R Soc Med 96 (Suppl. 43), 66-72. (Pubitemid 36842989)
26. Lessie, T. G., Hendrickson, W., Manning, B. D. & Devereux, R. (1996). Genomic complexity and plasticity of Burkholderia cepacia. FEMS Microbiol Lett 144, 117-128. (Pubitemid 26354315)
27. Lillard, J. W., Jr, Boyaka, P. N., Chertov, O., Oppenheim, J. J. & McGhee, J. R. (1999). The role of antimicrobial peptides in innate immunity. Proc Natl Acad Sci U S A 96, 651-656.
28. Linde, C. M., Grundström, S., Nordling, E., Refai, E., Brennan, P. J. & Andersson, M. (2005). Conserved structure and function in the granulysin and NK-lysin peptide family. Infect Immun 73, 6332-6339.
29. Mahenthiralingam, E. & Drevinek, P. (2007). Comparative genomics of Burkholderia species. In Burkholderia: Molecular Biology and Genomics. Edited by T. Coenye & P. Vandamme. Norwich, UK: Horizon Scientific Press.
30. Mahenthiralingam, E., Coenye, T., Chung, J. W., Speert, D. P., Govan, J. R. W., Taylor, P. & Vandamme, P. (2000). Diagnostically and experimentally useful panel of strains from the Burkholderia cepacia complex. J Clin Microbiol 38, 910-913. (Pubitemid 30082711)
31. Mahenthiralingam, E., Baldwin, A. & Dowson, C. G. (2008). Burkholderia cepacia complex bacteria: opportunistic pathogens with important natural biology. J Appl Microbiol 104, 1539-1551. (Pubitemid 351724983)
32. Matsuzaki, K., Sugishita, K., Fujii, N. & Miyajima, K. (1995). Molecular basis for membrane selectivity of an antimicrobial peptide, magainin 2. Biochemistry 34, 3423-3429.
33. Niyonsaba, F., Iwabuchi, A., Someya, A., Hirata, M., Matsuda, H., Ogawa, H. & Nagaoka, I. (2002). A cathelicidin family of human antibacterial peptide LL-37 induces mast cell chemotaxis. Immunology 106, 20-26. (Pubitemid 34437873)
34. Ohsaki, Y., Gazdar, A. F., Chen, H. C. & Johnson, B. E. (1992). Antitumor activity of magainin analogues against human lung cancer cell lines. Cancer Res 52, 3534-3538.
35. Ortega, X., Hunt, T. A., Loutet, S., Vinion-Dubiel, A. D., Dutta, A., Choudhury, B., Goldberg, J. B., Carlson, R. & Valvano, M. A. (2005). Reconstitution of O-specific lipopolysaccharide expression in Burkholderia cenocepacia strain J2315, which is associated with transmissible infections in patients with cystic fibrosis. J Bacteriol 187, 1324-1333. (Pubitemid 40299457)
36. Park, P. W., Pier, G. B., Hinkes, M. T. & Bernfield, M. (2001). Exploitation of syndecan-1 shedding by Pseudomonas aeruginosa enhances virulence. Nature 411, 98-102. (Pubitemid 32428197)
37. Rajyaguru, J. M. & Muszynski, M. J. (1997). Enhancement of Burkholderia cepacia antimicrobial susceptibility by cationic compounds. J Antimicrob Chemother 40, 345-351. (Pubitemid 27437952)
38. Reik, R., Spilker, T. & Lipuma, J. J. (2005). Distribution of Burkholderia cepacia complex species among isolates recovered from persons with or without cystic fibrosis. J Clin Microbiol 43, 2926-2928. (Pubitemid 40827976)
39. Schmidtchen, A., Frick, I. M., Andersson, E., Tapper, H. & Björck, L. (2002). Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL-37. Mol Microbiol 46, 157-168.
40. Scott, M. G., Yan, H. & Hancock, R. E. W. (1999). Biological properties of structurally related a-helical cationic antimicrobial peptides. Infect Immun 67, 2005-2009. (Pubitemid 29144428)
41. Sieprawska-Lupa, M., Mydel, P., Krawczyk, K., Wojcik, K., Puklo, M., Lupa, B., Suder, P., Silberring, J., Reed, M. & other authors (2004). Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases. Antimicrob Agents Chemother 48, 4673-4679. (Pubitemid 39577671)
42. Steinberg, D. A., Hurst, M. A., Fujii, C. A., Kung, A. H., Ho, J. F., Cheng, F. C., Loury, D. J. & Fiddes, J. C. (1997). Protegrin-1: a broad spectrum, rapidly microbicidal peptide with in vivo activity. Antimicrob Agents Chemother 41, 1738-1742. (Pubitemid 27339878)
43. Tew, G. N., Clements, D., Tang, H. Z., Arnt, L. & Scott, R. W. (2006). Antimicrobial activity of an abiotic host defense peptide mimic. Biochim Biophys Acta 1758, 1387-1392. (Pubitemid 44436076)
44. Thwaite, J. E., Hibbs, S., Titball, R. W. & Atkins, T. P. (2006). Proteolytic degradation of the human antimicrobial peptide LL-37 by Bacillus anthracis may contribute to virulence. Antimicrob Agents Chemother 50, 2316-2322. (Pubitemid 43993168)
45. Vanlaere, E., Lipuma, J. J., Baldwin, A., Henry, D., De Brandt, E., Mahenthiralingam, E., Speert, D., Dowson, C. & Vandamme, P. (2008). Burkholderia latens sp. nov., Burkholderia diffusa sp. nov., Burkholderia arboris sp. nov., Burkholderia seminalis sp. nov. and Burkholderia metallica sp. nov., novel species within the Burkholderia cepacia complex. Int J Syst Evol Microbiol 58, 1580-1590.
46. Zasloff, M. (1987). Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proc Natl Acad Sci U S A 84, 5449-5453. (Pubitemid 17129018)
47. Zasloff, M. (2002). Antimicrobial peptides of multicellular organisms. Nature 415, 389-395.